Cullinan therapeutics to participate in upcoming investor conferences

Cambridge, mass., aug. 28, 2024 (globe newswire) -- cullinan therapeutics, inc. (nasdaq: cgem; “cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced its participation in the following upcoming investor conferences:

CGEM Ratings Summary

CGEM Quant Ranking